Anti-TRAM1 monoclonal antibody

Pre-made anti-TRAM1 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to TRAM1/TRAM1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP2170-Ab-1/ GM-Tg-hg-IP2170-Ab-2Anti-Human TRAM1 monoclonal antibodyHuman
GM-Tg-rg-IP2170-Ab-1/ GM-Tg-rg-IP2170-Ab-2Anti-Rat TRAM1 monoclonal antibodyRat
GM-Tg-mg-IP2170-Ab-1/ GM-Tg-mg-IP2170-Ab-2Anti-Mouse TRAM1 monoclonal antibodyMouse
GM-Tg-cynog-IP2170-Ab-1/ GM-Tg-cynog-IP2170-Ab-2Anti-Cynomolgus/ Rhesus macaque TRAM1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP2170-Ab-1/ GM-Tg-felg-IP2170-Ab-2Anti-Feline TRAM1 monoclonal antibodyFeline
GM-Tg-cang-IP2170-Ab-1/ GM-Tg-cang-IP2170-Ab-2Anti-Canine TRAM1 monoclonal antibodyCanine
GM-Tg-bovg-IP2170-Ab-1/ GM-Tg-bovg-IP2170-Ab-2Anti-Bovine TRAM1 monoclonal antibodyBovine
GM-Tg-equg-IP2170-Ab-1/ GM-Tg-equg-IP2170-Ab-2Anti-Equine TRAM1 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP2170-Ab-1/ GM-Tg-hg-IP2170-Ab-2; GM-Tg-rg-IP2170-Ab-1/ GM-Tg-rg-IP2170-Ab-2;
GM-Tg-mg-IP2170-Ab-1/ GM-Tg-mg-IP2170-Ab-2; GM-Tg-cynog-IP2170-Ab-1/ GM-Tg-cynog-IP2170-Ab-2;
GM-Tg-felg-IP2170-Ab-1/ GM-Tg-felg-IP2170-Ab-2; GM-Tg-cang-IP2170-Ab-1/ GM-Tg-cang-IP2170-Ab-2;
GM-Tg-bovg-IP2170-Ab-1/ GM-Tg-bovg-IP2170-Ab-2; GM-Tg-equg-IP2170-Ab-1/ GM-Tg-equg-IP2170-Ab-2
Products NameAnti-TRAM1 monoclonal antibody
Formatmab
Target NameTRAM1
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-TRAM1 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP2170-Ag-1Recombinant multi-species TRAM1/ PNAS8/ TRAM protein
    ORF Viral VectorpGMLP002511human TRAM1 Lentivirus plasmid
    ORF Viral VectorvGMLP002511human TRAM1 Lentivirus particle
    ORF Viral VectorpGMLPm001840mouse Tram1 Lentivirus plasmid
    ORF Viral VectorvGMLPm001840mouse Tram1 Lentivirus particle


    Target information

    Target IDGM-IP2170
    Target NameTRAM1
    Gene ID23471,72265,312903,693963,403948,101097373,281546,100051585
    Gene Symbol and Synonyms1810049E02Rik,PNAS8,TRAM,TRAM1,TRAMP
    Uniprot AccessionQ15629,Q5XI41,Q01685,Q9GKZ4
    Uniprot Entry NameTRAM1_HUMAN,TRAM1_RAT,TRAM1_CANLF,TRAM1_BOVIN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseProstate Cancer
    Gene EnsemblENSG00000067167
    Target ClassificationN/A

    The target: TRAM1, gene name: TRAM1, also named as PNAS8, TRAM, TRAMP. This gene encodes a multi-pass membrane protein that is part of the mammalian endoplasmic reticulum. The encoded protein influences glycosylation and facilitates the translocation of secretory proteins across the endoplasmic reticulum membrane by regulating which domains of the nascent polypeptide chain are visible to the cytosol during a translocational pause. [provided by RefSeq, Oct 2009].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.